Gastroesophageal Reflux Disease (GERD) Market Insights Highlight Segment Expansion And Market Leadership

The gastroesophageal reflux disease (GERD) market is on a steady path of growth, driven by advances in treatment methods and increasing patient awareness. As medical technologies evolve and populations age, the market is expected to expand significantly over the coming years. Let's explore the market's size, key players, emerging trends, and the segments shaping its future.

Gastroesophageal Reflux Disease Market Size and Anticipated Growth Through 2030
The GERD market is projected to reach a value of $6.2 billion by the year 2030, growing at a compound annual growth rate (CAGR) of 3.3%. This positive trajectory is fueled by several factors, including the rising adoption of minimally invasive reflux procedures and a growing demand for long-term management of symptoms. Additionally, innovations in endoscopic devices, an increasing elderly population, and heightened patient awareness are contributing to the market's expansion. Key trends expected to influence growth include greater usage of proton pump inhibitors over extended periods, wider acceptance of minimally invasive techniques, enhanced awareness regarding lifestyle management of GERD, the expansion of endoscopic treatment options, and improved diagnosis through better screening methods.

The gastroesophageal reflux disease (gerd) market size has grown steadily in recent years. It will grow from $5.33 billion in 2025 to $5.46 billion in 2026 at a compound annual growth rate (CAGR) of 2.3%. The growth in the historic period can be attributed to widespread use of antacids and h2 blockers, rising obesity prevalence, high consumption of processed foods, increased clinical diagnosis rates, availability of generic ppis.

Download a free sample of the gastroesophageal reflux disease (gerd) market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12917&type=smp&utm_source=Open&utm_medium=Paid&utm_campaign=Aug_PR

Leading Companies Driving the Gastroesophageal Reflux Disease Market Forward
Several prominent companies play a crucial role in the GERD market landscape. These include GlaxoSmithKline PLC, SRS Life Sciences, Takeda Pharmaceutical Company Limited, AstraZeneca Plc, Reckitt Benckiser Group Plc, Eisai Co. Ltd., Pfizer Inc., Medtronic Plc, Teva Pharmaceuticals, HK inno.N Corporation, Mylan N.V., Johnson & Johnson MedTech, Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, Cipla Limited, Amneal Pharmaceuticals LLC, Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd., and Salix Pharmaceuticals Inc.

A significant development in the sector occurred in July 2024 when Merit Medical Systems, Inc., a US-based healthcare technology provider, acquired EndoGastric Solutions, Inc. Although the financial details were not disclosed, this move expanded Merit's portfolio in minimally invasive endoscopy and reinforced its position in the GERD treatment market. EndoGastric Solutions is known for the EsophyX Z+ system, a transoral incisionless fundoplication device designed to treat chronic GERD effectively.

View the full gastroesophageal reflux disease (gerd) market report:
https://www.thebusinessresearchcompany.com/report/gastroesophageal-reflux-disease-gerd-global-market-report?utm_source=Open&utm_medium=Paid&utm_campaign=Aug_PR

Emerging Trends Influencing Growth in the GERD Market
Innovation remains a key focus for companies in the GERD space as they strive to maintain competitive advantage by launching advanced treatment devices. For example, in April 2023, Laborie Medical Technologies, a US-based medical device firm, introduced the alpHaONE wireless pH-capsule reflux testing system. This diagnostic tool offers continuous monitoring for up to 96 hours and features a compact design with enlarged buttons and a fail-safe capsule delivery mechanism. It also includes a user-friendly software application with virtual instructions and customizable symptom buttons to enhance patient experience.

The Role of Advanced Diagnostics and Device Innovation
The increasing use of cutting-edge diagnostic technologies reflects a broader trend toward personalized and precise management of GERD. By enabling longer monitoring periods and improved ease of use, devices like the alpHaONE system are helping clinicians better understand reflux patterns and tailor treatments accordingly. Such innovations are expected to drive patient compliance and overall market expansion in the coming years.

Breakdown of Key Segments in the GERD Market
This report categorizes the gastroesophageal reflux disease market into several essential segments to offer a comprehensive view:
1) Drug Types: Includes Antacids, Proton Pump Inhibitors, H2 Receptor Blockers, Prokinetic Agents, and Dopamine Receptor Antagonists.
2) Procedures: Divided into Invasive and Minimally Invasive methods.
3) End-Users: Covers Hospitals, Homecare settings, and Specialty Clinics.

Further detailed subcategories include antacid variants like Calcium Carbonate, Magnesium Hydroxide, and Aluminum Hydroxide. Proton pump inhibitors are broken down into drugs such as Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, and Rabeprazole. H2 receptor blockers consist of Ranitidine, Famotidine, Nizatidine, and Cimetidine. Prokinetic agents include Metoclopramide and Domperidone, while dopamine receptor antagonists cover Prochlorperazine and Droperidol.

This segmentation provides a nuanced understanding of market dynamics and helps identify growth opportunities across different treatment approaches and consumer bases.

Our 2026 market reports now offer broader strategic coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, along with updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.